Effect of probiotics in peritoneal dialysis patients

Effect of probiotics on mean differences of hsCRP and ESR in peritoneal dialysis patients:a double blind randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017031329812N3

Enrollment

Registered

2017-03-27

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephropathy. Other dialysis

Interventions

intervention(probiotic, for two months).

Treatment - Drugs

intervention(probiotic, for two months)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion critera: uremic patients on peritoneal dialysis for three months and more, older than 15 years. Exclusion criteria: uremic patients with advanced malignancy, uremic patients with an interval of at least three months from the last peritonitis episodes, uremic patients with active infectious disease, uremic patients with uncontrolled autoimmune diseases such as lupus

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
CRP-Hs. Timepoint: At baseline and Two months after the initiation of trial. Method of measurement: dl/g.;ESR. Timepoint: At baseline and Two months after the initiation of trial. Method of measurement: mm/h.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Najafee

Nephrology Department, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

farzaneh najafee@yahoo.com+98 35 3822 4001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026